Observational analysis shows reduced risk of type 2 diabetes and liver disease in individuals adhering to the EAT-Lancet reference diet, implying improved health outcomes.
Higher adherence to the EAT-Lancet reference diet is associated with lower risk of type 2 diabetes, metabolic dysfunction-associated steatotic liver disease, and their co-occurrence.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: